Gene · 1376
Papers2,286
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,286
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential. | Front Immunol | 2023 | 37675125 | PubTator, text mining | PubMed |
| Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling. | Nat Commun | 2023 | 37673856 | PubTator, text mining | PubMed |
| Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients. | BMC Biol | 2023 | 37667308 | PubTator, text mining | PubMed |
| Molecular, enzymatic responses and in vitro embryonic developmental competency of heat-shocked buffalo embryos co-cultured with granulosa cells monolayer. | Theriogenology | 2023 | 37659251 | PubTator, text mining | PubMed |
| Harnessing metabolism of hepatic macrophages to aid liver regeneration. | Cell Death Dis | 2023 | 37644019 | PubTator, text mining | PubMed |
| Comparative Study of ZnO-and-TiO2-Nanoparticles-Functionalized Polyvinyl Alcohol/Chitosan Bionanocomposites for Multifunctional Biomedical Applications. | Polymers (Basel) | 2023 | 37631534 | PubTator, text mining | PubMed |
| Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy. | Metabolites | 2023 | 37623876 | PubTator, text mining | PubMed |
| TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation. | Nat Commun | 2023 | 37607907 | PubTator, text mining | PubMed |
| Fasting-Mimicking Diet Drives Antitumor Immunity against Colorectal Cancer by Reducing IgA-Producing Cells. | Cancer Res | 2023 | 37602826 | PubTator, text mining | PubMed |
| Genetics of enzymatic dysfunctions in metabolic disorders and cancer. | Front Oncol | 2023 | 37601653 | PubTator, text mining | PubMed |
| Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation. | Oxid Med Cell Longev | 2023 | 37600065 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
Variations in Anxiety and Related Psychiatric Comorbidity Levels Among Youths With Individual Diagnoses of Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder and Those With Both Diagnoses. | Cureus | 2023 | 37575727 | PubTator, text mining | PubMed |
| The Effects of a Curcumin Derivative and Osimertinib on Fatty Acyl Metabolism and Mitochondrial Functions in HCC827 Cells and Tumors. | Int J Mol Sci | 2023 | 37569564 | PubTator, text mining | PubMed |
| Breast cancers as ecosystems: a metabolic perspective. | Cell Mol Life Sci | 2023 | 37561190 | PubTator, text mining | PubMed |
| Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes. | JCI Insight | 2023 | 37552540 | PubTator, text mining | PubMed |
| From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification. | Gut | 2023 | 37549980 | PubTator, text mining | PubMed |
| Evaluation of L-Carnitine Potential in Improvement of Male Fertility. | J Reprod Infertil | 2023 | 37547570 | PubTator, text mining | PubMed |
| Clinico-histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease. | Cancer Sci | 2023 | 37545384 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes. | Sci Rep | 2023 | 37543674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1376/papers?page=13